Based on this approach, we identified in silico five novel SMYD3 interactors selected for their enrichment in P-tripeptides and their prominent role in five cancer hallmark-related clusters for which no SMYD3 interactor was known to date. This evidence concerns the gene SMYD3 and cancer.